|
Volumn 314, Issue 7083, 1997, Pages 796-800
|
Hormone replacement therapy and risk of venous thromboembolism: population based case-control study.
a a a a
a
Novartis Pharma
(Spain)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AGED;
ARTICLE;
CASE CONTROL STUDY;
COHORT ANALYSIS;
DOSE RESPONSE;
ESTROGEN THERAPY;
FEMALE;
HUMAN;
LUNG EMBOLISM;
MIDDLE AGED;
RISK FACTOR;
THROMBOEMBOLISM;
AGED;
CASE-CONTROL STUDIES;
COHORT STUDIES;
DOSE-RESPONSE RELATIONSHIP, DRUG;
ESTROGEN REPLACEMENT THERAPY;
FEMALE;
HUMANS;
MIDDLE AGED;
PULMONARY EMBOLISM;
RISK FACTORS;
THROMBOEMBOLISM;
MLCS;
MLOWN;
|
EID: 0031569043
PISSN: 09598138
EISSN: None
Source Type: Journal
DOI: 10.1136/bmj.314.7083.796 Document Type: Article |
Times cited : (317)
|
References (0)
|